Is MV-CHIK a promising candidate vaccine for the prevention of chikungunya fever?

Findings from a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial
Findings from a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial